Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs) are often used to treat outpatients with psychogenic somatoform symptoms but prove ineffective in some cases. The metabolite 3-hydroxybutyrate (3HB) is currently attracting attention a...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Norihiro, Itoga, Masamichi, Minakawa, Satoko, Kayaba, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121269/
https://www.ncbi.nlm.nih.gov/pubmed/34007205
http://dx.doi.org/10.2147/IJGM.S300517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121269/
https://www.ncbi.nlm.nih.gov/pubmed/34007205
http://dx.doi.org/10.2147/IJGM.S300517

Ejemplares similares